期刊文献+

阿尔采末病免疫治疗的动物实验与临床试验进展 被引量:2

Advance in immunotherapy of Alzheimer's disease in animal experimentations and clinical trials
原文传递
导出
摘要 阿尔采末病是老年痴呆发生的主要原因,如何控制和缓解阿尔采末病是近年来研究热点。免疫治疗在清除脑组织淀粉样蛋白和改善认知功能方面有明显优势,随着一系列动物实验和临床试验的开展,免疫治疗应用于阿尔采末病将成为可能。本文将从主动免疫治疗和被动免疫治疗2个方面,综述阿尔采末病免疫治疗的动物实验和临床试验研究进展。 Alzheimer’s disease(AD) is the major cause of dementia,and how to ameliorate the symptom or prevent the progression of AD has become a focus now.The immunotherapy has great advantages in clearing the brain’s amyloid plaque and improving the patient’s recognition.With the development of animal experimentations and clinical trials,the immunotherapy of AD can be used for curing the patients with AD in the future.This paper provided an overview of advance in immunotherapy of AD in animal experimentations and clinical trials.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2010年第9期641-645,共5页 Chinese Journal of New Drugs and Clinical Remedies
基金 国家863项目(2006AA02A408) 上海市国际合作项目(075407066 10410712900)
关键词 阿尔采末病 免疫疗法 主动 免疫疗法 被动 动物实验 临床试验 Alzheimer’s disease immunotherapy active immunotherapy passive animal experimentation clinical trials
  • 相关文献

参考文献29

  • 1BROOKMEYER R, JOHNSON E, ZIEGLER-GRAHAM K, et al. Forecasting the global burden of Alzheimer's disease [J]. Alzheimers Dement, 2007, 3(3): 186-191.
  • 2梁妍琦,黄霄天,唐希灿.阿尔采末病发病机制及治疗药物研究进展[J].中国新药与临床杂志,2006,25(9):641-648. 被引量:11
  • 3SCHENK D, BARBOUR R, DUNN W, et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse[J]. Nature, 1999, 400(6740) : 173-177.
  • 4JANUS C, PEARSON J, MCLAURIN J, et al. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease [J]. Nature, 2000, 408 (6815) : 979-982.
  • 5DAS P, MURPHY MP, YOUNKIN LH, et al. Reduced effectiveness of Abetal-42 immunization in APP transgenic mice with significant amyloid deposition[J]. Neurobiol Aging, 2001, 22 (5) : 721-727.
  • 6ODDO S, VASILEVKO V, CACCAMO A, et al. Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles [J]. J Biol Chem, 2006, 281 (51) : 39413-39423.
  • 7FERRER I, BOADA ROVIRA M, SANCHEZ GUERRA ML, et al. Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease [J]. Brain Pathol, 2004, 14(1): 11-20.
  • 8HOCK C, KONIETZKO U, STREFFER JR, et al. Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease [J]. Neuron, 2003, 38(4): 547-554.
  • 9HOLMES C, BOCHE D, WILKINSON D, et al. Long-term effects of Abetad2 immunisation in Alzheimer's disease: follow-up of a randomised,placebo-controlled phase I trial[J]. Lancet, 2008, 372(9634) : 216-223.
  • 10MONSONEGO A, ZOTA V, KARNI A, et al. Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease[J]. J Clin Invest, 2003, 112 (3) : 415- 422.

二级参考文献16

  • 1沈一峰,李华芳,马崔,陈远光,范俭雄,蓝长安,程能能,顾牛范.瑞波西汀与氟西汀治疗抑郁症随机双盲多中心临床研究[J].中国新药与临床杂志,2005,24(8):619-623. 被引量:10
  • 2颜菡,唐希灿.石杉碱甲国内临床应用回顾[J].中国新药与临床杂志,2006,25(9):682-688. 被引量:15
  • 3Wang R Yan H Tang XC.Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine[J].中国生物学文摘,2006,20(10):20-20. 被引量:70
  • 4FINKEL SI.Behavioral and psychological symptoms of dementia: a current focus for clinicians, researchers, and caregivers[J]. J Clin Psychiatry, 2001, 62 Suppl 21:3-6.
  • 5BLACK W, ALMEIA OP. A systematic review of the association between the behavioral and psychological symptonls of dementia and burden of care[J]. Int Psychogeriatr, 2004, 16(3):295-315.
  • 6FINKEL SI, BURNS A, COHEN GD. Over review of behavioral and psychological symptoms of dementia [J]. Int Psychogeriatr. 2000. 12 Suppl 1 : 13-18.
  • 7FERRI CP, AMES D, PRINCE M, et al. Behavioral and psychological symptoms of dementia in developing countries[J], Int Psychogeriatr, 2004, 16(4) :441-459.
  • 8JOST BC, GROSSBERG GT. The evaluation of psychiatric symptoms in Alzheimer's disease: a natural history study[J]. J Am Geriatr Soc, 1996, 44(9) : 1078-1081.
  • 9MIRAKHUR A, CRAIG D, HART DJ, et al. Behavioural and psychological syndromes in Alzheimer's disease[J], Int J Geriatr Psychiatry, 2004, 19(11) :1035-1039.
  • 10TANAKA Y, MEGURO K, YAMAGUCHI S, et al. Decreased striatal D2 receptor density associated with severe behavioral abnormality in Alzheimer's disease[J]. Ann Nucl Med, 2003, 17(7) : 567-573.

共引文献16

同被引文献19

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部